Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
55 hedge funds and large institutions have $57.8M invested in Derma Sciences, Inc. Common Stock (DE) in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 10 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
7% less funds holding
Funds holding: 59 → 55 (-4)
38% less capital invested
Capital invested by funds: $93.5M → $57.8M (-$35.8M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $143K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$707K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$381K |
| 3 |
Renaissance Technologies
New York
|
+$343K |
| 4 |
UBS AM
Chicago,
Illinois
|
+$326K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$2.53M |
| 2 |
SM
Senvest Management
New York
|
-$2.02M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.88M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$1.42M |
| 5 |
AIC
AWM Investment Company
New York
|
-$864K |
DSCI Hedge Fund Activity: Q1 2016 in Review
55 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2016, worth a combined $57.8M — down 38% from $93.5M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of DSCI and 6 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 18 added.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $707K. The largest seller was Consonance Capital Management, cutting an estimated $2.53M.
- 55 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2016, down from 59 in Q4 2015.
- Funds reported $57.8M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2016, down 38% quarter-over-quarter.
- 6 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2016 and 10 closed out, a net change of -4 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2016 was Manulife (Manufacturers Life Insurance), an estimated $707K added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2016 was Consonance Capital Management, an estimated $2.53M sold.
Based on aggregated 13F filings for Q1 2016.